 UBS Group AG cut its stake in shares of NGM Biopharmaceuticals NYSE:NGM by 60.5 in the 1st quarter, according to the company in its most recent filing with the Securities Exchange Commission. The fund owned 10,534 shares of the companys stock after selling 16,125 shares during the period. UBS Group AGs holdings in NGM ... 